Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

The video discusses a trial for Moderna's experimental mRNA COVID-19 vaccine, involving 30,000 volunteers. Unlike traditional vaccines, it uses mRNA to trigger an immune response. Participants receive either the vaccine or a placebo, and researchers monitor them for COVID-19 infections. Moderna aims to produce up to 1 billion doses by 2021, with potential protection lasting up to two years.

What new insight or understanding did you gain from this video?